Low- vs. high-dose radiotherapy in Graves’ ophthalmopathy: a retrospective comparison of long-term results

[1] Bradley EA(2008)Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology Ophthalmology 115 398-409

[2] Gower EW(2010)Graves’ ophthalmopathy N Engl J Med 362 726-738

[3] Bradley DJ(2016)Graves’ orbitopathy Klin Monbl Augenheilkd 233 1385-1407

[4] Meyer DR(2007)Pathogenesis of Graves’ ophthalmopathy: the role of autoantibodies Thyroid 17 1013-1018

[5] Cahill KV(2018)2018 European thyroid association guideline for the management of Graves’ hyperthyroidism Eur Thyroid J 7 167-186

[6] Custer PL(1998)Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL Br J Ophthalmol 82 773-779

[7] Holck DE(1990)Orbital decompression for Graves’ ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach Ophthalmology 97 636-641

[8] Woog JJ(2017)Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement Orphanet J Rare Dis 12 72-13

[9] Bahn RS(2011)Medical management of thyroid eye disease Saudi J Ophthalmol 25 3-954

[10] Eckstein A(1993)Randomized double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy Lancet 342 949-11

[1] Bradley EA(2008)Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology Ophthalmology 115 398-409

[2] Gower EW(2010)Graves’ ophthalmopathy N Engl J Med 362 726-738

[3] Bradley DJ(2016)Graves’ orbitopathy Klin Monbl Augenheilkd 233 1385-1407

[4] Meyer DR(2007)Pathogenesis of Graves’ ophthalmopathy: the role of autoantibodies Thyroid 17 1013-1018

[5] Cahill KV(2018)2018 European thyroid association guideline for the management of Graves’ hyperthyroidism Eur Thyroid J 7 167-186

[6] Custer PL(1998)Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL Br J Ophthalmol 82 773-779

[7] Holck DE(1990)Orbital decompression for Graves’ ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach Ophthalmology 97 636-641

[8] Woog JJ(2017)Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement Orphanet J Rare Dis 12 72-13

[9] Bahn RS(2011)Medical management of thyroid eye disease Saudi J Ophthalmol 25 3-954

[10] Eckstein A(1993)Randomized double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy Lancet 342 949-11